LI
ABBV icon

LifeWealth Investments’s AbbVie ABBV Stock Holding History

LifeWealth Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Buy
1,726
+171
+11% +$36.8K 0.12% 91
2026
Q1 		$338K Sell
1,555
-452
-23% -$100K 0.1% 100
2025
Q4 		$459K Buy
2,007
+548
+38% +$125K 0.15% 93
2025
Q3 		$338K Buy
1,459
+32
+2% +$6.52K 0.11% 103
2025
Q2 		$265K Buy
1,427
+135
+10% +$25.1K 0.1% 124
2025
Q1 		$271K Buy
+1,292
New +$251K 0.13% 104

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LifeWealth Investments's ABBV Position: Q2 2026 in Review

LifeWealth Investments increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $36.8K and bringing the position to 1,726 shares worth $434K. The position accounts for 0.12% of the portfolio, ranked #91.

LifeWealth Investments first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $459K in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LifeWealth Investments held 1,726 shares of AbbVie worth $434K as of Q2 2026.
  • LifeWealth Investments bought 171 AbbVie shares in Q2 2026, an estimated $36.8K.
  • AbbVie made up 0.12% of LifeWealth Investments's portfolio in Q2 2026, its #91 holding.
  • LifeWealth Investments first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • LifeWealth Investments's AbbVie position peaked at $459K in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LifeWealth Investments's 13F filing for Q2 2026, filed 16 Jul 2026.